Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Letter in reference to "Real-world evidence regarding cancer, mortality, and graft failure risk with de novo belatacept use among kidney transplant recipients in the United States".
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: April 08, 2025
Identification of indirect CD4+ T cell epitopes associated with transplant rejection provides a target for donor-specific tolerance induction.
Journal: Immunity
Published: April 17, 2024
Memory T follicular helper cells drive donor-specific antibodies independent of memory B cells and primary germinal center and alloantibody formation.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Published: April 14, 2023
Costimulatory Blockade and Solid Organ Transplantation: The Past, Present, and Future.
Journal: Kidney international reports
Published: April 03, 2023
Implementation of an Online Intraoperative Assessment of Technical Performance for Surgical Trainees.
Journal: The Journal of surgical research
Published: January 26, 2023
Three-year Outcomes After Conversion From Monthly to Every 2-month Belatacept Maintenance Therapy in Kidney Transplant Recipients: Results From a Randomized Controlled Trial.
Journal: Transplantation direct
Published: November 14, 2022
Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high-risk cytomegalovirus serostatus kidney transplant recipients.
Journal: Transplant infectious disease : an official journal of the Transplantation Society
Published: July 22, 2022
Indeterminate group A subtyping for prospective renal transplant donor.
Journal: Transfusion
Published: April 28, 2022
Belatacept in Kidney Transplant Recipients With Failed Allografts for the Prevention of Humoral Sensitization: A Pilot Randomized Controlled Trial.
Journal: Transplantation
Published: November 24, 2021
CXCL13 Is an Indicator of Germinal Center Activity and Alloantibody Formation Following Transplantation.
Journal: Transplantation direct
Published: September 17, 2021
Belatacept Conversion in Kidney After Liver Transplantation.
Journal: Transplantation direct
Published: July 20, 2021
Temporal trends and current use of de novo belatacept in kidney transplant recipients in the United States.
Journal: Clinical transplantation
Published: April 16, 2021
Last Updated: 09/26/2026